Propanc Biopharma, Inc. Receives Nasdaq Delisting Notice Over $1.00 Minimum Bid Price Requirement

Propanc Biopharma received an October 23, 2026, written notice from Nasdaq’s Listing Qualifications Department that it does not comply with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The provided article text does not state any cure period, further consequences, or company response.